1. Solid pavestones are needed to pave a solid way to success

   • Haidong Dong

   Editorial 27 November 2019 Pages: 1 - 1

   

2. Mechanisms of immune evasion in bladder cancer

   • Paul L. Crispen
   • Sergei Kusmartsev

   Review Open access 06 December 2019 Pages: 3 - 14

   

3. Association of immune-related pneumonitis with the presence of preexisting interstitial lung disease in patients with non-small lung cancer receiving anti-programmed cell death 1 antibody

   • Ryota Shibaki
   • Shuji Murakami
   • Yuichiro Ohe

   Original Article 19 November 2019 Pages: 15 - 22

   

4. Characterization of tumor-infiltrating immune cells in relation to microbiota in colorectal cancers

   • Tomohiro Kikuchi
   • Kosaku Mimura
   • Koji Kono

   Original Article 26 November 2019 Pages: 23 - 32

   

5. VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer

   • Liju Zong
   • Yuncan Zhou
   • Yang Xiang

   Original Article Open access 28 November 2019 Pages: 33 - 42

   

6. Proteolytic processing of PD-L1 by ADAM proteases in breast cancer cells

   • Yeni Romero
   • Randi Wise
   • Anna Zolkiewska

   Original Article 03 December 2019 Pages: 43 - 55

   

7. A highly efficient modality to block the degradation of tryptophan for cancer immunotherapy: locked nucleic acid-modified antisense oligonucleotides to inhibit human indoleamine 2,3-dioxygenase 1/tryptophan 2,3-dioxygenase expression

   • Richard Klar
   • Sven Michel
   • Frank Jaschinski

   Original Article 04 December 2019 Pages: 57 - 67

   

8. Interleukin-38 in colorectal cancer: a potential role in precision medicine

   • Feier Chen
   • Feng Zhang
   • Kun Tao

   Original Article 30 November 2019 Pages: 69 - 79

   

9. GCN2 is essential for CD8⁺ T cell survival and function in murine models of malignant glioma

   • Aida Rashidi
   • Jason Miska
   • Maciej S. Lesniak

   Original Article 16 December 2019 Pages: 81 - 94

   

10. Tailoring early-phase clinical trial design to address multiple research objectives

    • Nolan A. Wages
    • Craig L. Slingluff Jr.
    • Gina R. Petroni

    Original Article 05 December 2019 Pages: 95 - 102

    

11. CD200 mimetic aptamer PEG-M49 markedly increases the therapeutic effects of pegylated liposomal doxorubicin in a mouse model of metastatic breast carcinoma: an effect independent of CD200 receptor 1

    • Nuray Erin
    • Sayra Dilmaç
    • Reginald M. Gorczynski

    Original Article 06 December 2019 Pages: 103 - 114

    

12. IL-17A promotes fatty acid uptake through the IL-17A/IL-17RA/p-STAT3/FABP4 axis to fuel ovarian cancer growth in an adipocyte-rich microenvironment

    • Chunyan Yu
    • Xiulong Niu
    • Weimin Deng

    Original Article 04 December 2019 Pages: 115 - 126

    

13. Tumor mutation burden and immunological, genomic, and clinicopathological factors as biomarkers for checkpoint inhibitor treatment of patients with non-small-cell lung cancer

    • Yuki Ozaki
    • Satoshi Muto
    • Hiroyuki Suzuki

    Original Article 06 December 2019 Pages: 127 - 134

    

14. Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models

    • Rui Zhang
    • Fengjiao Yuan
    • Li Yang

    Original Article Open access 05 December 2019 Pages: 135 - 145

    

15. Chemotherapy markedly reduces B cells but not T cells and NK cells in patients with cancer

    • Johanna Waidhauser
    • Anja Schuh
    • Andreas Rank

    Original Article 03 January 2020 Pages: 147 - 157

    

16. Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy

    • Nadia Mensali
    • Marit Renée Myhre
    • Else Marit Inderberg

    Correction Open access 27 November 2019 Pages: 159 - 161